Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Introduction to Virus01:28

Introduction to Virus

2.1K
Viruses are unique biological entities that blur the boundary between living and non-living systems. Although they lack cellular structure and metabolic processes, they can exhibit characteristics of life when infecting a host. Their defining feature is a nucleic acid core, composed of either DNA or RNA, encapsulated within a protein coat called a capsid. This simple structure allows them to invade host cells and use their machinery for replication efficiently.Viral Structure and...
2.1K
What are Viruses?00:50

What are Viruses?

128.8K
Overview
128.8K
Viruses of Archaea01:29

Viruses of Archaea

592
Archaeal viruses play a crucial role in the ecosystems of extremophilic archaea, particularly those belonging to the phyla Euryarchaeota and Crenarchaeota. By shaping host evolution and facilitating gene transfer, these viruses influence microbial communities and contribute to genetic diversity in extreme environments. The archaea they infect thrive in acidic hot springs and hydrothermal vents characterized by high temperatures and low pH. Archaeal viruses exhibit remarkable structural...
592
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

1.1K
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.1K
Viral Structure00:56

Viral Structure

75.1K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
75.1K
Intracellular Movement of Viruses and Bacteria01:10

Intracellular Movement of Viruses and Bacteria

3.7K
Intracellular bacteria and viruses often comprise a group of highly infectious pathogens that can cause several diseases. Bacterial pathogens include those belonging to the genus Rickettsia responsible for conditions such as rocky mountain spotted fever and the Mediterranean spotted fever; Chlamydia, a genus responsible for a sexually transmitted disease; Coxiella burnetii, an agent responsible for Q fever. Viral pathogens include vaccinia—a poxvirus, and herpes simplex virus—a...
3.7K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Effectiveness of baloxavir marboxil in nonhuman primates infected with highly pathogenic avian influenza A(H7N9) virus.

EBioMedicine·2026
Same author

A CRISPR knockout mouse library for functional genomics in influenza research.

Cell·2026
Same author

Niclosamide inhibits the replication of highly pathogenic avian influenza A (H5Nx) viruses and antiviral-resistant mutants.

Antiviral research·2026
Same author

Using Machine Learning to Identify Factors Affecting Antibody Production and Adverse Reactions After COVID-19 Vaccination.

Vaccines·2026
Same author

Impact of Vaccination and Prior Infection on SARS-CoV-2 Viral Load in Preschool Children During the Omicron Pandemic.

Vaccines·2025
Same author

Structural basis of broad protection against influenza virus by human antibodies targeting the neuraminidase active site via a recurring motif in CDR H3.

Nature communications·2025

関連する実験動画

Updated: Mar 2, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

37.1K

エボラウイルスの弱点

Seiya Yamayoshi1, Yoshihiro Kawaoka2

  • 1Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan.

Cell
|May 20, 2017
PubMed
まとめ

研究者はエボラウイルスのグリコタンパク質に 重要な欠陥を発見しました この部位を標的とした抗体は エボラウイルスの5つのタイプを全て無効化し 普遍的なエボラ治療の道を開きました

さらに関連する動画

Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses
12:20

Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses

Published on: December 29, 2015

22.1K
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

10.4K

関連する実験動画

Last Updated: Mar 2, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

37.1K
Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses
12:20

Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses

Published on: December 29, 2015

22.1K
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

10.4K

科学分野:

  • ウイルス学
  • 免疫学
  • 薬物の発見

背景:

  • エボラウイルス病 (EVD) は,世界的な健康問題です.
  • エボラウイルスのグリコタンパク質はウイルスの侵入に不可欠であり,治療的介入のターゲットです.

研究 の 目的:

  • エボラウイルスのグリコプロテイン内の保存された脆弱性を特定します.
  • パン・エボラウイルス免疫療法のための 広く中和する抗体を開発する.

主な方法:

  • 保存された領域を特定するためにエボラウイルスのグリコタンパク質構造の分析.
  • 免疫された被験者と生存者のモノクローナル抗体の分離と特徴付け
  • 多種エボラウイルスに対する抗体中和活性評価

主要な成果:

  • 2つの研究では,エボラウイルスのグリコプロテイン内の保存された内部融合ループが脆弱性であると特定されました.
  • この融合ループを標的としたモノクローナル抗体は,5つのエボラウイルスすべてに対して強力な中和性を示した.
  • これらの抗体は免疫によって誘発され,生き残ったヒトから隔離されました.

結論:

  • エボラウイルスのグリコタンパク質の内部融合ループは,広範囲のEVD治療の重要な標的である.
  • この保存されたエピトープを標的とした汎エボラウイルス免疫療法の開発は可能である.
  • これらの発見は様々なエボラウイルス株と戦う戦略を進めている.